Disclaimer: this software uses AI to aggregate and filter content. Please double-check sources before putting info to action.
📰 News Media
- 📚 [New Hampshire] Literature program gets grant to support recovery services and combat opioid epidemic - nhpr.org
- 🌿 [Boston, MA] Curaleaf, $2.6 billion cannabis company, opens store in downtown Boston, over social equity protests - bostonglobe.com
- 🧑 [National] In recovery, helping helps the helper IF… - recoveryreview.blog
🗣️ Social Pulse
Lived/Living Experience
- No posts found today.
Innovation
- 🧪 Membertou Community FB page: Community Notice – Please Be Aware Membertou Health Centre has issued a Community Drug Alert following a report that cannabis used in Membertou tested positive for fentanyl. Community... - @MBSNewsMaritime on X
- 🚨 NEW emerging illicit drug threat. It’s called Medetomidine and it’s being found in Fentanyl supplies. If there’s interest in these types of alerts, I’ll share them more often‼️ - @DuchessOfMeme on X
Opposition Views
🏙 City Updates
- No recent City Updates found.
📚 Academic Research
- 🧪 Advancing Spectroscopy‐Based Drug Checking Training: A Proof‐of‐Concept Study for the Use of Concordance Analysis - Drug and Alcohol Review - 2026-09-01 - doi.org
- 💉 Opioid Overdose Risk and Recovery Barriers: A Mixed Methods Study of Perspectives From a Community - Public Health Reports® - 2026-09-06 - doi.org
- 💊 Community-Level Determinants of Buprenorphine Provider Availability: A ZCTA-Level (Zip Code Tabulation Area) Analysis - Drug and Alcohol Dependence Reports - 2026-09-01 - doi.org
⚖️ Law & Policy
- No hits in Law and Policy today.
💸 Funding
Current
- Deadline Approaching💊 Bureau of Justice Assistance - BJA FY 2026 Comprehensive Opioid, Stimulant, and Substance Use Site-Based Program - Deadline: Sep 24, 2026
- 🔬 National Institutes of Health - Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) - Deadline: Sep 30, 2026
- 🔬 National Institutes of Health - Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) - Deadline: Jun 16, 2028
- 🔬 National Institutes of Health - Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) - Deadline: Aug 21, 2028
- 🔬 National Institutes of Health - Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) - Deadline: Sep 25, 2028
- 🔬 National Institutes of Health - HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional) - Deadline: Feb 9, 2029
- 🏥 Hearst Foundations - Health - Hearst Foundations (Health) — Year-Round, Rolling Grant Application (No Deadlines) - Minimum grant size is $100,000. - Deadline: Year-round, rolling application; there are no deadlines.
- 🏥 Hearst Foundations - Social Service - Hearst Foundations — Social Service (year-round rolling applications) - Minimum grant size is $100,000. (No other amounts stated on this FAQ page.) - Deadline: Year-round, rolling application; there are no deadlines.
- 🤝 Smart Family Fund - First time grants ranging from $25,000 to $100,000. - Deadline: Open pitch